ELUTMICRO

Elutia Inc.

HealthcareBiotechnology
$1.00
$0.00(+5.37%)
52W$0.50
$2.64
Updated Jun 29, 02:00 AM
RSI42
RS Rating68/99
Beta0.03
Volatility82%
F-Score5/9
Mkt Cap$44M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Elutia Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 68), indicating performance broadly in line with the market. Earnings growth of 19% provides fundamental context to the price action. Investors should exercise caution due to high volatility (82% annualized), which requires wider risk management.

Relative Strength
68
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.03
vs S&P 500
LOW VOL
52W Position
23%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.05
50 SMA > 100 SMA$1.07
100 SMA > 150 SMA$0.95
150 SMA > 200 SMA$0.95

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.01-0.81%BELOW
50 SMA$1.05-4.90%BELOW
100 SMA$1.07-6.62%BELOW
150 SMA$0.95+4.89%ABOVE
200 SMA$0.95+5.08%ABOVE

Price Performance

1D+5.4%
1W-0.1%
1M-12.4%
3M-6.6%
6M+83.6%
YTD+55.4%
1Y-46.0%
3Y-23.8%
52-Week Trading Range23% from low
$1.00
52W Low$0.50
52W High$2.64

Technical Indicators

RSI (14)NEUTRAL
42.4
305070
Setup ScoreCOOL
4/10
Base depth: 35.0%

Risk Profile

Beta
0.03
52W Vol
82%
ATR
$0.08
Max DD (1Y)
-79%

Volume Analysis

Today
50D Avg
104.4K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+77%
$-0.26
Q3'25+42%
$-0.19
Q4'25+669%
$1.48
Q1'26+19%
$-0.17
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:-22.04%
3 Years:-19.82%
TTM:-32.64%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+144.56%

Stock Price CAGR

10 Years:-23.47%
5 Years:-37.60%
3 Years:-23.82%
1 Year:-46.00%

Return on Equity

10Y Avg:-207.9%
5Y Avg:-242.3%
3Y Avg:192.9%
Last Year:192.9%

Key Metrics

Market Cap$44M
Gross Margin53.7%
Net Margin4.3%
Piotroski F-Score5/9

Frequently Asked Questions

Is ELUT in an uptrend right now?

ELUT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ELUT overbought or oversold?

ELUT's RSI (14) is 42. The stock is in neutral territory, neither overbought nor oversold.

Is ELUT outperforming the market?

ELUT has a Relative Strength (RS) Rating of 68 out of 99. ELUT is performing about average compared to the market.

Where is ELUT in its 52-week range?

ELUT is trading at $1.00, which is 38% of its 52-week high ($2.64) and 23% above its 52-week low ($0.50).

How volatile is ELUT?

ELUT has a Beta of 0.03 and 52-week volatility of 82%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.